Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-08-05 19:01:41 ET · period of report 2026-08-05 · accession 0001886794-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-05 19:01 | 2026-08-05 | PCVX | Dhaliwal Harpreet S. | Chief Technical Ops Off | M - OptEx | $24.79 | +17.0K | 93.8K | +22% | +$421.4K |
| DT | 2026-08-05 19:01 | 2026-08-05 | PCVX | Dhaliwal Harpreet S. | Chief Technical Ops Off | S - Sale+OE | $55.00 | -17.0K | 76.8K | -18% | -$935.1K |
| DT | 2026-08-05 19:01 | 2026-08-05 | PCVX | Dhaliwal Harpreet S. | Chief Technical Ops Off | M - OptEx | $0.00 | -17.0K | 28.0K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-05 | M | A | 17,000 | $24.79 | 93,756 | D | — | — | (F1) Includes 780 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |
| 2 | Common | Common Stock | 2026-08-05 | S | D | 17,000 | $55.00 | 76,756 | D | — | — | (F2) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026. (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $55.00 to $55.255. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (right to buy) | 2026-08-05 | M | D | 17,000 | $0.00 | 28,000 | D | $24.79 · — to 2032-03-02 | 17,000 Common Stock | (F4) Stock Option is fully vested and exercisable. |